Curaleaf: Analysts Anticipate Q1 Revenues to Hit US$254 Million

Curaleaf Holdings (CSE: CURA) is expected to release their first quarter financial results after the close of markets today. Analysts have a consensus C$27.86 12-month price target on the company, via a total of 15 analysts, with four analysts having a strong buy rating and the other 11 have buy ratings. The street high comes from BTIG with a C$34 price target, and the lowest target comes from Cormark Securities with a C$24 price target.

Fourteen analysts have revenue estimates for the first quarter. The mean between all 14 is U$254.09 million; this number has been revised downwards from U$267.07 million at the start of the year. The highest revenue estimate U$263.80, while the lowest comes from MKM Partners with a U$251 million estimate.

Eleven analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 50.25%, with this number staying flat year to date. Street high goes to BTIG with a 54.80% estimate and the lowest sits at 40% from Ladenburg Thalmann.

Onto EBITDA estimates, there are currently 13 analysts who have first quarter EBITDA estimates. The mean is currently U$60.24 million, with this number being revised downwards from U$69.15 million at the start of the year. Street high goes to Cantor Fitzgerald with a U$65.60 million EBITDA estimate and the lowest being from BTIG with a U$53.90 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Well Health: PI Financial Raises Price Target To $7.00 On Back Of Circle Acquisition

This week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US...

Friday, September 4, 2020, 01:38:00 PM

Verano Holdings: Canaccord Initiates With $35 Price Target

Earlier this month Canaccord initiated coverage on Verano Holdings (CSE: VRNO) with a C$35 price...

Monday, March 22, 2021, 10:41:00 AM

K92 Mining Sees BMO Reiterate $11 Price Target Following Q3 Production Results

On October 6th, K92 Mining Inc. (TSX: KNT) reported it’s third-quarter production results. The company...

Tuesday, October 11, 2022, 11:19:00 AM

BMO Expects Miners To Be Hit With Cost Inflation Headwinds In Q1 Results

On April 18, BMO released their first quarter preview on their metals and mining coverage,...

Thursday, April 21, 2022, 11:28:00 AM

Curaleaf Receives Approval For TSX Listing

Curaleaf Holdings (CSE: CURA) is officially leaving the Canadian Securities Exchange. The company has been...

Thursday, December 7, 2023, 08:58:30 AM